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Abstract
Background
Galanin, an inhibitory neuropeptide and cotransmitter has long been known to co-localize
with noradrenaline and serotonin in the central nervous system. Several human studies
demonstrated altered galanin expression levels in major depressive disorder and anxiety.
Pharmacological modulation of galanin signaling and transgenic strategies provide further
proof for the involvement of the galanin system in the pathophysiology of mood disorders.
Little is known, however, on the dynamic regulation of galanin expression at the transcrip-
tional level. The aim of the present study was to seek genetic association of non-coding sin-
gle nucleotide variations in the galanin gene with anxiety and depression.
Methods
Six single nucleotide polymorphisms (SNP) occurring either in the regulatory 5’ or 3’ flanking
regions or within intronic sequences of the galanin gene have been genotyped with a high-
throughput TaqMan OpenArray qPCR system in 526 healthy students (40% males).
Depression and anxiety scores were obtained by filling in the Hospital Anxiety and Depres-
sion Scale (HADS) questionnaire. Data were analyzed by ANCOVA and Bonferroni correc-
tion was applied for multiple testing. Linkage disequilibrium (LD) analysis was used to map
two haploblocks in the analyzed region.
Results and conclusions
A single-locus and a haplotype genetic association proved to be statistically significant. In
single-marker analysis, the T allele of the rs1042577 SNP within the 3’ untranslated region
of the galanin gene associated with greater levels of anxiety (HADS scores were 7.05±4.0
vs 6.15±.15; p = 0.000407). Haplotype analysis revealed an association of the rs948854
C_rs4432027_C allele combination with anxiety [F(1,1046) = 4.140, p = 0.042141, η2 =
0.004, power = 0.529]. Neither of these associations turned out to be gender-specific.
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These promoter polymorphisms are supposed to participate in epigenetic regulation of
galanin expression by creating potentially methylatable CpG dinucleotides. The functional
importance of the rs1042577_T allele remains to be elucidated.
Introduction
Common affective disorders such as depression and anxiety emerge against the background of
perturbed monoaminergic neurotransmission. Beyond the well-substantiated role of classical
neurotransmitters such as norepinephrin and serotonin in the pathogenesis of mood disor-
ders, a number of recent studies implicated coexpressed neuropeptides such as galanin, a 29
amino acid long inhibitory neurotransmitter and trophic factor [1], in anxiety and depression
[2]. A Bayesian multivariate analysis of gene factors revealed that the galanin signaling system
consisting of the stress-inducible galanin gene and three heptahelical galanin receptors seems
to play a seminal role in the development of depression by enhancing the vulnerability to envi-
ronmental stressors [3].
However, the exact function of galanin in depression still remains elusive. Data gained
from animal studies suggest that galanin mediates depression-like behaviour [4], while other
authors emphasize its antidepressant-like effects [5, 6].
Experimental data argue that the effects of galanin on anxiety are brain region specific and
all three galanin receptors seem to mediate its anxiety-like effects. Intracerebroventricular
administration of galanin resulted in anxiolytic-like action in rats [7], while its microinjection
in rodent amygdala produced both anxiogenic [8] and anxiolytic effects [9]. The anxiolytic
action was more predominant when galanin was infused into the dorsal raphe nucleus in rats
[10]. However, intra-dorsal hippocampal administration of galanin induced anxiogenic-like
behaviours that could be attenuated with a type 2 galanin receptor antagonist [11].
Importantly, these seemingly contradictory findings could be reconciled by showing that
type 1 and type 2 galanin receptors mediate opposite anxiety-like effects in the rat dorsal raphe
nucleus [12]. The anxiolytic action of the type 2 galanin receptor is underscored by the fact
that Gal2R knockout mice exhibit an anxiogenic-like phenotype [13], while type 3 galanin
receptor knockout animals display increased anxiety [14]. Polymorphisms in the gene encod-
ing galanin receptor 2 seem to mediate the effect of environmental stressors and gene-environ-
ment interactions [15].
Differential expression of galanin has been implicated in a broad spectrum of neuropsychi-
atric disorders including post-traumatic stress disorder [16] and Lewy body disorder [17].
Human studies revealed a direct correlation between plasma galanin levels and the severity of
major depressive disorder [18]. In contrast, intravenous administration of galanin to depressed
individuals exerted fast antidepressant activity [19]. Moreover, profound alterations in mRNA
expression and DNA methylation have been found in the galanin system in postmortem brain
samples of patients with major depressive disorder [20].
Though the regulation of galanin expression is far from being fully characterized, some
transcription factors [21], medicine [22] and exercise [22, 23] have been shown to upregulate
galanin transcription. Several lines of compelling evidence suggest that non-coding DNA vari-
ations affecting important 5’ and 3’ regulatory as well as intronic sequences are associated with
central nervous system disorders such as panic disorder [24], depression and anxiety [25–28]
via altering transcription factor or microRNA binding sites.
As described above, other authors have already demonstrated associations between GAL
polymorphisms and mood disorders, but no studies have been done to date to test this possible
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association in a non-clinical, largely normal, healthy sample. Thus, our goal was to figure out
whether any genetic association is detectable between a set of marker SNPs representing the
entire regulatory landscape of the galanin gene and mood characteristics in an ostensibly nor-
mal sample consisting of university students with no psychiatric history.
Materials and methods
Subjects
To test possible genetic associations between GAL polymorphisms and anxiety and depression,
DNA samples from a previous study on anxiety were genotyped for GAL polymorphisms [29].
Thus, participants of the present investigation largely overlap with those of an earlier genetic
association study where the associations of glial cell derived neurotrophic factor (GDNF) poly-
morphisms with mood characteristics were tested [29]. The non-related Caucasian (Hungar-
ian) subjects who participated on a voluntary basis were students from several educational
institutions from Budapest, Hungary. They gave written informed consent, provided buccal
cell samples and filled out the Hospital Anxiety and Depression Scale (HADS) questionnaire.
The study protocol was designed in accordance with guidelines of the Declaration of Helsinki,
and was approved by the Scientific and Research Ethics Committee of the Medical Research
Council (ETT TUKEB). Inclusion criteria were as follows: no past or present psychiatric his-
tory (based on self-report), age between 18–35 years, valid GDNF SNP genotypes and valid
self-report data for the HADS scales.
A total of 597 independent subjects were genotyped with a high-throughput system, and
filled out the HADS self-report questionnaire. Of them, 589 had no previous psychiatric his-
tory and 526 subjects were between 18–35 years. Therefore, we analyzed data from 526 partici-
pants (40.7% males, 59.3% females; mean age: 22.01 ± 3.1 years).
Phenotype characteristics
As described in our previous study on anxiety [29], participants completed the Hungarian ver-
sion [30] of the Hospital Anxiety and Depression Scale [31]. The HADS questionnaire mea-
sures anxiety and depression on 7–7 items, scoring on a 0 to 3 Likert scale. It was originally
developed to assess anxiety and depression in case of non-psychiatric hospital patients [31].
However, a great deal of studies have shown that it is an adequate tool to measure mood char-
acteristics on non-clinical samples as well [32]. The Cronbach Alpha values of the HADS scales
were adequate (Cronbach Alpha = 0.775 for the anxiety and 0.715 for the depression scale,
respectively). The inter-correlation of the two scales was high (r = 0.561, p< 0.001). The sam-
ple’s mean scores were 6.55 (± 3.7) on the anxiety scale and 2.80 (± 2.7) on the depression
scale.
SNP selection criteria
Single nucleotide polymorphisms (SNPs) were selected for genotyping from the Single Nucleo-
tide Polymorphism database of NCBI (dbSNP) with a minor allele frequency greater than 0.05.
The pairwise tagging method using r2 threshold of 0.8 by Haploview was used to determine
tagging SNPs based on HapMap data to obtain a proper coverage of the GAL gene resulting in
a mean distance of 1721 bp between the selected SNPs. Polymorphisms with a reference from
previous association studies concerning neuropsychiatric disorders were preferred.
Anxiety and galanin genetic variants
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DNA preparation and SNP genotyping
Genomic DNA samples were isolated from buccal swabs as described previously [29]. Geno-
types were determined applying the TaqMan1OpenArray™ Genotyping System (Thermo
Fisher Scientific, Waltham, Massachusetts) that is based on sequence-specific, fluorescent Taq-
Man probes in combination with a high-throughput PCR system using nanoliter-scale sample
volume and post-PCR (endpoint) detection. Genotyping panels were obtained from the manu-
facturer as immobilized target specific primers and fluorescent probes in a low density array
format. Reaction mixtures containing approximately 100 ng DNA (range: 30–150 ng) and the
1× master mix (each deoxyribonucleoside triphosphate and the AmpliTaq Gold DNA-poly-
merase, provided by the manufacturer) were prepared on a 384-well sample plate and then
loaded on the genotyping plates by the OpenArray™ Autoloader. PCR amplification was per-
formed in the GeneAmp1 PCR System 9700 (Thermo Fisher Scientific, Waltham, Massachu-
setts) following the manufacturer’s instruction. Endpoint imaging of the allele specific FAM
and VIC fluorescent intensities was made by the OpenArray™ NT Imager. Raw data were eval-
uated by the TaqMan Genotyper v1.2 software.
2% of the DNA samples were repeatedly applied on the OpenArray system, demonstrating
a reproducibility exceeding 98%. In addition, a subsample was re-genotyped for two SNPs
with a 7300 Real-Time PCR System (Applied Biosystems, Foster City, CA) in triplicates for
quality control.
Table 1 summarizes the main characteristics of six SNPs genotyped within the GAL gene.
Genotype, chromosomal position, relative distances in the gene body and regional localisation
for the tested GAL polymorphisms are presented for each SNP. Genotype frequencies, p values
from the Hardy-Weinberg equilibrium (HWE) tests and call rate information are also pre-
sented. The rs694066 SNP exhibited an outstandingly small minor genotype frequency (0.8%),
Table 1. Main characteristics of the studied SNPs in the GAL gene.
dbSNP
number
Position Distance Region N % HWE Call rate
rs948854 TT g.68682735 5’ flanking 260 50.0 P = 0.996 98.86%
CT - 216 41.5
CC 44 8.5
rs2097042 TT g.68682846 5’ flanking 233 50.7 P = 0.999 87.26%
CT 111 188 41.0
CC 38 8.3
rs4432027 TT g.68683779 5’ flanking 251 51.3 P = 0.762 92.97%
CT 933 194 39.7
CC 44 9.0
rs694066 GG g.68685517 intron 2 399 79.2 P = 0.682 95.82%
AG 1738 101 20.0
AA 4 0.8
rs3136540 CC g.68688942 intron 5 260 56.7 P = 0.938 87.26%
CT 3425 169 36.8
TT 30 6.5
rs1042577 CC g.68691002 3’-UTR 180 40.1 P = 0.983 85.36%
CT 2060 210 46.8
TT 59 13.1
HWE = Hardy-Weinberg equilibrium; UTR = untranslated region. Distance: distance between chromosomal positions of neighboring SNPs in base pairs.
https://doi.org/10.1371/journal.pone.0226228.t001
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while the others vary between 6.5% and 13.1%. All genotypes were in Hardy-Weinberg equilib-
rium. Call rates exceeded 85% for each polymorphism.
Linkage disequilibrium analyses
Lewontin’s D’ as well as R2 values of linkage disequilibrium were determined using the Haplo-
View 4.2 software [33]. Haplotypes were determined by the Phase programme [34–36]. Link-
age disequilibrium values of the studied SNPs are displayed in Fig 1. Importantly, both
Lewontin’s D’ and R2 analysis revealed two haplotype blocks. Haplotype block No. 1 encom-
passes rs948854, rs2097042, rs4432027 and rs694066 SNPs, while rs3136540 and rs1042577
belong to haplotype block No. 2.
Statistical analysis
Statistical analyses were carried out using SPSS 20.0 for Windows. Chi-square analysis was
used to assess reliability of the measured genotype and allele frequencies. Lewontin’s D’ as well
as R2 values of linkage disequilibrium were calculated using the HaploView 4.2 application
[33]. Haplotypes were determined by the Phase program. To test gender differences, the Inde-
pendent-Samples t-test was used. Correlation analyses were carried out to test the HADS scales
relationship with age. One-way analyses of covariance (ANCOVA) was used to test genetic
associations of the single and multiple marker analyses in an allele-wise design. Bonferroni
correction for multiple testing was used to rule out false positive results [37]. The corrected
level of significance was p< 0.00417, as the nominal p (threshold value 0.05) was divided by
the number of analyses performed (6 SNPs x 2 HADS scales = 12). Two-way ANOVA was
used for testing the effect of prior associations in males and females.
Results
Influence of age and gender on anxiety and depression scores
Testing for covariates included testing the relationships between age, gender and the measured
phenotypes and genotypes. The HADS anxiety scale showed significant differences across
males and females [t(524) = - 4.054; p<0.001]; namely, females showed a higher mean score
Fig 1. Linkage disequilibrium plots for the studied GAL SNPs. Lewontin’s D’ measure (panel A) and R2 values
(panel B) of linkage disequilibrium. Larger figures and darker squares indicate stronger pairwise linkage
disequilibrium between two loci.
https://doi.org/10.1371/journal.pone.0226228.g001
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(7.09) than males (5.78). The HADS depression scale did not differ across genders. For testing
the relationship between age and the HADS scales, Pearson correlation was used. The anxiety
scale significantly correlated with age (r = - 0.89, p = 0.042), while the depression scale showed
no significant correlation. The genotype frequency differences in males and females were
tested with Chi-square analyses and no significant differences were observed. The ANOVAs
testing the genotype and age association did not show any significant association either. In
summary, age and gender were used as covariates in all association analyses on account of
their association with the phenotype.
Single-allele association analyses on mood characteristics with GAL
polymorphisms
Table 2 summarizes the results obtained from the single-allele association analyses. Minor
allele frequencies, anxiety and depression mean scores for the alleles of each tested SNPs are
presented with the corresponding p values. Based on the one-way ANCOVAs, three nominally
significant associations were found with the anxiety scale, and one with the depression scale.
The results showed higher anxiety mean scores associated with the minor allele of rs948854 [F
(1,136) = 3.865, p = 0.049572, η2 = 0.004, power = 0.502], rs4432027 [F(1,974) = 4.349,
p = 0.037297, η2 = 0.004, power = 0.549] and rs1042577 [F(1,894) = 12.594, p = 0.000407,
η2 = 0.014, power = 0.944]. The minor allele of rs1042577 associated with a higher mean score
on the depression scale as well [F(1,894) = 5.718, p = 0.016996, η2 = 0.006, power = 0.666].
Bonferroni correction was applied to rule out possible false positive effects. After correcting
for multiple testing, association of anxiety and rs1042577 remained significant. In the presence
of the minor allele (T) of the rs1042577 the mean anxiety score was significantly higher (7.05
±4.0) as compared to the major allele (G) carriers (6.15±3.5). The effect of this polymorphism
explained 1.4% of the variability of anxiety. In this analysis, the covariate effect of gender but
not that of age proved to be significant (p< 0.001).
Table 2. Association analyses between GAL polymorphisms and mood characteristics as measured by HADS questionnaire.
dbSNP
number
MAF�� mMAF��� Anxiety p Depression p
rs948854 C 0.319 0.292 6.91 (±4.1) 0.049572 2.95 (±3.0) 0.315956
T 6.45 (±3.5) 2.76 (±2.5)
rs2097042 C 0.265 0.288 6.81 (±3.9) 0.073644 2.91 (±3.0) 0.424516
T 6.36 (±3.5) 2.75 (±2.5)
rs4432027 C 0.321 0.288 6.86 (±4.1) 0.037297 2.93 (±3.0) 0.318117
T 6.34 (±3.5) 2.74 (±2.5)
rs694066 A 0.136 0.109 6.58 (±4.4) 0.925477 2.83 (±2.9) 0.728726
G 6.49 (±3.6) 2.76 (±2.6)
rs3136540 T 0.262 0.250 6.77 (±4.0) 0.188575 2.83 (±2.8) 0.602540
C 6.44 (±3.6) 2.71 (±2.5)
rs1042577 T 0.373 0.358 7.05 (±4.0) 0.000407� 3.01 (±3.0) 0.016996
C 6.15 (±3.5) 2.59 (±2.4)
p: level significance (ANOVA with age and sex as covariant).
�Significant after Bonferroni correction (12 tests: p<0.004167).
��MAF: minor allele frequency (based on data from the 1000 Genome project).
���mMAF: measured minor allele frequency. (Standard deviations are shown in parenthesis)
https://doi.org/10.1371/journal.pone.0226228.t002
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Haplotype analyses
As a next step, haplotype analyses were performed involving the three SNPs significantly asso-
ciated with anxiety comparing the combined effects of the risk alleles versus non-risk alleles.
To this end, bipartite and tripartite haplotypes were set up by pairing the most significantly
associated rs1042577 3’ UTR SNP with one or both of the less significantly associated 5’ SNPs
as shown in Table 3. Upon comparing haplotype frequencies, it is striking that two major hap-
lotypes are represented with outstanding frequency in each category. For example, in case of
the rs1042577—rs948854 haplotypes the non-risk-allele combination (rs1042577 C—rs948854
T) and the one containing both risk alleles (rs1042577 T—rs948854 C) occurred most fre-
quently (0.692 and 0.254, respectively, as compared to 0.040 and 0.014 of the C-C and T-T
haplotypes). Similarly, in case of the tripartite haplotype a few combinations were very rare
(e.g. rs1042577 C, rs948854 C, rs4432027 T: 0.001) or even unrepresented in the present sam-
ple (e.g. C–T–C or T–C- T). In case of all three analyses, the two major haploalleles made up
about 95% of all haplotypes. The low frequency of some haplotypes is probably due to the high
linkage between the SNPs (see Fig 1).
Thus, the haplotype analyses were carried out between the two most frequent haplotypes.
One-way ANCOVAs were applied to both mood dimensions with the haploalleles of the sig-
nificant SNPs from haploblock 1 (rs948854—rs4432027) and from both haploblocks
(rs1042577—rs948854, rs1042577—rs4432027, rs1042577- rs948854—rs4432027). Age and
gender were also included as covariates. As it can be seen in Table 4, the haplotype with the
risk alleles of both 5’ UTR SNPs (rs948854_C—rs4432027_C) showed significantly higher anx-
iety mean score than the haplotype with non-risk alleles [F(1,1046) = 4.140, p = 0.042141,
η2 = 0.004, power = 0.529]. Unexpectedly, however, any bi- or tripartite haplotype comprising
the risk allele of the 3’ UTR SNP (rs1042577) which associated significantly with anxiety even
after correcting for multiple testing, did not prove to be associated either with anxiety or
depression.
Table 3. Haplotype frequencies in the studied population.
Haplotypes� N Frequency
rs1042577 C—rs948854 T 728 0.692
rs1042577 C—rs948854 C 42 0.040
rs1042577 T—rs948854 T 15 0.014
rs1042577 T—rs948854 C 267 0.254
rs1042577 C—rs4432027 T 729 0.693
rs1042577 C—rs4432027 C 41 0.039
rs1042577 T—rs4432027 T 14 0.013
rs1042577 T—rs4432027 C 268 0.255
rs1042577 C—rs948854 T–rs4432027 T 728 0.692
rs1042577 C—rs948854 C–rs4432027 T 1 0.001
rs1042577 C—rs948854 T–rs4432027 C 0.000
rs1042577 C—rs948854 C–rs4432027 C 41 0.039
rs1042577 T—rs948854 T–rs4432027 T 14 0.013
rs1042577 T—rs948854 T–rs4432027 C 1 0.001
rs1042577 T—rs948854 C–rs4432027 T 0.000
rs1042577 T—rs948854 C–rs4432027 C 267 0.254
�risk alleles in the haplotypes are displayed bold
https://doi.org/10.1371/journal.pone.0226228.t003
Anxiety and galanin genetic variants
PLOS ONE | https://doi.org/10.1371/journal.pone.0226228 December 27, 2019 7 / 13
Gender-specific effects
The HADS anxiety scores differed across the genders, and the covariate effect of gender was
also significant in the analysis of rs1042577 and anxiety. Thus, we raised the question whether
the effect of this single-locus SNP was gender-specific. To address this issue, a two-way
ANOVA was carried out to test whether the effect of rs1042577 in the single-locus analyses dif-
fered between males and females. Results are presented in Fig 2. The analysis revealed a signifi-
cant GAL rs1042577 main effect [F(1,893) = 11.571, p = 0.0007, η2 = 0.013, power = 0.925],
and a significant gender main effect [F(1,893) = 21.253, p< 0.001, η2 = 0.023, power = 0.996].
However, their interaction was not significant. According to these results, the risk effect of the
T allele of the GAL rs1042577 SNP for higher anxiety scores was present in both genders.
Males with the T allele showed a mean anxiety score of 6.21 (±3.9) and the females’ mean anxi-
ety score with this allele was 7.65 (±3.9) as compared to the 5.48 (±3.6) and 6.61 (±3.4) mean
scores with the C allele in males and females. The significant gender main effect is in accor-
dance with literary data [38], suggesting that females in general show higher anxiety scores
than males.
Furthermore, we also tested whether the association between the rs948854—rs4432027 hap-
lotype and anxiety is gender specific. The two-way ANOVA showed a significant rs948854—
rs4432027 haplotype main effect [F(1, 1046) = 4.449, p = 0.035, η2 = 0.004, power = 0.559], a
significant gender main effect [F(1,893) = 25.603, p< 0.001, η2 = 0.024, power = 0.999], but
the interaction between the rs948854—rs4432027 haplotype and gender was not significant.
According to the results (Fig 3), the risk haplotype group showed a higher mean anxiety score
both in males (6.24 ± 4.2) and females (7.36 ± 3.9), as compared to the non-risk haplotype
groups of males (5.57 ± 3.4) and females (6.98 ±3.5).
Discussion
Galanin has been shown to co-localize with and modulate the release of norepinephrine and
serotonin, principal neurotransmitters in depression and anxiety. In contrast to former
research aimed to find genetic associations between GAL gene variants and mood characteris-
tics in subjects with clinical anxiety and depression [, the novelty of the present study is that it
was performed on a cohort of apparently normal, healthy volunteers. Candidate single nucleo-
tide polymorphisms were carefully selected to cover 5’ and 3’ regulatory as well as intronic
sequences of the gene, and polymorphisms with previous association data were preferred.
Genetic association analyses of six GAL single nucleotide polymorphisms with anxiety and
depression have been carried out with one-way analyses of covariance in an allele-wise
Table 4. Haplotype analysis of risk alleles.
Haplotypes� N Frequency Anxiety p Depression p
rs1042577 C _rs948854 T 728 0.692 6.41 (±3.54) 0.075066 2.76 (±2.52) 0.260648
rs1042577 T_rs948854 C 267 0.254 6.83 (±4.10) 2.99 (±3.11)
rs1042577 C_rs4432027 T 729 0.693 6.41 (±3.54) 0.059088 2.75 (±2.52) 0.226432
rs1042577 T_rs4432027 C 268 0.255 6.85 (±4.11) 3.00 (±3.11)
rs948854 T_rs4432027 T 742 1.000 6.42 (±3.52) 0.042141 2.74 (±2.51) 0.309043
rs948854 C_rs4432027 C 308 0.293 6.89 (±4.05) 2.93 (±3.02)
rs1042577 C_rs948854 T_rs4432027 T 728 0.692 6.41 (±3.54) 0.075066 2.76 (±2.52) 0.260648
rs1042577 T_rs948854 C_rs4432027 C 267 0.254 6.83 (±4.10) 2.99 (±3.11)
�risk alleles in the haplotypes are displayed bold. (Standard deviations are shown in parenthesis)
https://doi.org/10.1371/journal.pone.0226228.t004
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method. Allele frequencies calculated from our population corresponded very well to those
available from the 1000 Genomes project. Four nominally significant single-locus associations
have been observed in the present study. While GAL rs948854 and rs4432027 SNPs were
found to associate with anxiety, the rs1042577 SNP was significantly associated with both anxi-
ety and depression. The association between rs1042577 and anxiety remained significant fol-
lowing correction for multiple testing. The minor allele of this polymorphism is coupled with
higher anxiety mean score (T) as compared to the major allele (C). This association was
observable in both females and males.
Recent studies conducted on healthy samples also found that HADS anxiety and depression
scores varied a lot among university students [39–41]. Importantly, our healthy sample was
also quite stratified as 9.9% of the sample (n = 52) scored higher than 11 (mean score of
14.23 ± 2.278) and 11.4% of the sample (n = 60) scored lower than 3 (mean: 1.32 ± 0.673) on
the anxiety scale. On the other hand, 9.7% of the sample (n = 51) scored higher than 6 (mean:
9.160 ± 1.902) and 11.6% scored 0 on the depression scale. These data imply that approxi-
mately 10% of our admittedly healthy sample had clinical anxiety and depression [32]. It is to
note that the frequency of the rs1042577 risk T allele was significantly higher in the top 9.9%
than in the bottom 11.4% anxiety groups (50.0% vs. 30.6%, p = 0.005, data not shown).
Haplotype analysis is a very effective tool to test possible allelic interactions. In the present
study, comparing the risk allele of rs1042577 from haploblock 2 (see Fig 1) and the risk alleles
of the other two SNPs from haploblock 1 (rs948854 and rs4432027) which showed nominally
significant associations with anxiety did not yield any significant associations. However, signif-
icant association between haplotype rs948854 C_rs4432027_C and anxiety was observed sug-
gesting a possible additive effect of the risk alleles in this haploblock.
The chromosomal distance between these SNPs is slightly more than 1 kb. Importantly, the
C allele of each SNP is followed by a guanine nucleotide, creating CpG dinucleotides as
Fig 2. Effect of GAL rs1042577 alleles on anxiety in males and females. Mean HADS anxiety scores in males and
females as a function of GAL rs1042577 alleles. Open symbols denote females; filled symbols stand for males. Error
bars represent standard errors of the mean.
https://doi.org/10.1371/journal.pone.0226228.g002
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potential DNA methylation sequences in the promoter [42]. One can therefore assume that
their methylation might elicit anxiety via diminished galanin expression. High-resolution
methylation mapping of the galanin promoter and functional studies are needed to clarify this
assumption. Notably, the role of DNA methylation in the regulation of the galanin system was
already suggested by Barde et al. [20].
To our best knowledge, this is the first study in the literature shedding light on the associa-
tion of the rs1042577 single nucleotide variation with any phenotype. Though this polymor-
phism was analyzed in a study by Unschuld et al. [24], it was not found to be associated with
panic disorder. Apart from psychiatric studies, Scha¨uble et al. [43] also tested this polymor-
phism, addressing the role of galanin in fat intake and early onset obesity but failed to find
associations.
The rs1042577 SNP is localized to the 3’ untranslated region of the galanin gene, a sequence
where miRNA binding sites are frequently found. In an attempt to ascribe a functional role to
this polymorphism, we searched the online PolymiRTS Database 3.0 (http://compbio.uthsc.
edu/miRSNP/) but it turned out that this polymorphism does not affect any known miRNA
target sequences. It is also possible that this SNP affects mRNA stability or half-life by allele-
specific recruitment of RNA binding proteins but this assumption lacks yet experimental evi-
dence. The rs1042577 SNP is found within a weak CTCF binding site in the 3’UTR. This tran-
scription factor plays multiple roles in transcriptional modulation and chromatin architecture
Fig 3. Effect of the GAL rs948854—rs4432027 haplotype on anxiety in males and females. Mean HADS anxiety scores in males and females as a function of GAL
rs948854—rs4432027 haplotypes. Open symbols denote females; filled ones stand for males. Error bars represent standard errors of the mean.
https://doi.org/10.1371/journal.pone.0226228.g003
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[44]. The issue whether it really binds the 3’ UTR in the context of chromatin needs further
investigation.
In summary, in this study we revealed two statistically significant associations between anx-
iety and the galanin rs948854_C–rs4432027_C haplotype and the rs1042577_T single-locus
allele, respectively. These results should be corroborated using clinical samples and functional
analyses should also be performed, addressing the role these sequence variants might play in
governing galanin expression.
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